the pain I was experiencing with my tongue/ had extreme pain around the right side of my tongue; it went in to my jaw and in to my ear.; it went in to my jaw and in to my ear.; had a hard time talking, swallowing and eating; had a hard time talking, swallowing and eating; had a hard time talking, swallowing and eating; The initial case was missing the following minimum criteria: No adverse event. Upon receipt of follow-up information on 20Jun2023, this case now contains all required information to be considered valid.  This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID: (159558). The reporter is the patient.  A 65-year-old female patient received BNT162b2 (BNT162B2), on 14Dec2021 as dose 3 (booster), single (Lot number: 33130BA, Expiration Date: 28Feb2022) at the age of 65 years, in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. Vaccination history included: BNT162b2 (Dose 1, single, Lot# (First Dose): EW0164, Expiration Date (First Dose): Consumer stated, "I don't have it."), administration date: 19Apr2021, when the patient was 64-year-old, for COVID-19 Immunization; BNT162b2 (Lot# (Dose 2, single): Consumer stated, "I believe its EW0183."), administration date: 10May2021, when the patient was 65-year-old, for COVID-19 Immunization. The following information was reported: GLOSSODYNIA (non-serious) with onset Jan2022, outcome "recovered", described as "the pain I was experiencing with my tongue/ had extreme pain around the right side of my tongue"; SPEECH DISORDER (non-serious), DYSPHAGIA (non-serious), EATING DISORDER (non-serious) all with onset 2022, outcome "unknown" and all described as "had a hard time talking, swallowing and eating"; PAIN IN JAW (non-serious), EAR PAIN (non-serious) all with onset 2022, outcome "unknown" and all described as "it went in to my jaw and in to my ear.". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of glossodynia.  Additional information: Reported as, Patient told her that we are not able to link some and our next step would be to file a report with you and that you guys are not able to determine if the link correlates with what she received, patient did make her aware of that and then patient did confirm with our customer service department that she received the Pfizer COVID Monovalent, purple cap and she states that she 67 now, however during her reaction she was 65 at the time as the reaction happened in Jan2022. Other Medical Conditions or Other Medications: Consumer stated, "I take Vitamins, that's what I take". Consumer stated, "No, but I did undergo a series of lab tests after the two weeks time period because patient was going to different doctors and patient finally ended up at a Neurologist who ordered a number of blood tests to be done as well as a MRI. Treatment: Consumer stated, "They gave me at a clinic that was surely after it was Magic mouthwash that have Lidocaine in it to get in some of the pain patient was experiencing with her tongue, one of them was Magic mouthwash and patient was not able to see a infectious disease Doctor until May and at that time she put her on a antiviral medication, patient was not able to see a Doctor, an antiviral medication doctor until May and she put me on Valtrex 1 gm, it's an antiviral medication. When probed what reactions patient experienced, Consumer stated, "I had extreme pain around the right side of my tongue and that was the only reaction at that time, I had a hard time talking, swallowing and eating, after I had the antiviral medications in May2022, I then felt, it relieved the pain that I was experiencing but then I was exposed to COVID in Sep2022 and it started all over again except this time it went in to my jaw and in to my ear." Reassurance: Consumer stated, "No, except that I would like somebody to follow-up on this and patient was trying to determine if anyone else has experienced anything like patient have". Consumer was informed that the previous department, Pfizer Medical Information was the concerned department for the query. There was a product complaint to report. She was calling in regards to the Pfizer COVID vaccine. She states she received a booster dose on 14Dec2021 (14Dec2021) in (withheld) and two weeks later she had a a severe reaction, she provided that she has been through N number of tests and doctors and she was trying to find out if the vaccine was linked to her reaction. She wanted to determine if there has been some side effects from the vaccine. Caller mentioned that she had a possible side effect from the booster shot after 2 weeks she had the vaccine.  No follow-up attempts are possible. No further information is expected.